KeyCorp reiterated coverage on Harvard Bioscience with a new price target

3/10/21 5:04:31 PM ET

Biotechnology: Laboratory Analytical Instruments

Industrials

KeyCorp reiterated coverage of Harvard Bioscience with a rating of and set a new price target of $9.00 from $6.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$HBIO

Date	Price Target	Rating	Analyst
4/9/2025		Overweight → Sector Weight	KeyBanc Capital Markets
3/10/2023	$3.00 → $4.00	Speculative Buy → Buy	The Benchmark Company